Skip to main content

Year: 2021

Law Firms Verrill and Rackemann Combine, Forming a New Regional, Full-Service Powerhouse

The combination significantly expands the size of Verrill’s Boston office and the service offerings of the two firmsFrank A. De Vito, Rackemann’s Managing Director, and Keith C. Jones, Verrill’s Managing PartnerLaw Firms Verrill and Rackemann Combine, Forming a New Regional, Full-Service PowerhouseBOSTON, Dec. 21, 2021 (GLOBE NEWSWIRE) — New England-based law firms Verrill Dana LLP (Verrill) and Rackemann, Sawyer, & Brewster (Rackemann) announce that they will combine effective January 1, 2022. The newly combined firm will operate as Verrill, with Rackemann’s entire professional and administrative staff relocating to Verrill’s Boston offices at One Federal Street over the next several months. With the combination, Verrill’s Boston office will expand to 60 lawyers, and the firm’s overall attorney...

Continue reading

Brookfield REIT Grows to $1.5 Billion of Total Asset Value With Acquisition of DreamWorks Animation Campus, Two Apartment Buildings and Three Logistics Facilities

15-Acre DreamWorks Facility in Glendale, CA Acquired for $326.5 Million; 445 Apartment Units Acquired for $172 Million; 500,000 Square Feet of Logistics Real Estate Acquired for $71 Million BROOKFIELD NEWS, Dec. 21, 2021 (GLOBE NEWSWIRE) — Brookfield today announced that it has acquired the DreamWorks Animation Campus in Glendale, CA for $326.5 million. The 15-acre, 500,000-square-foot facility, located in Los Angeles’ media district, serves as DreamWorks’ headquarters and includes all essential infrastructure for the creation of animated feature films and television series including production and motion-capture studios, green rooms, a commissary and a 165-seat theater. The seven-building campus houses approximately 1,500 employees at the studio – including artists, animators, technologists and engineers. DreamWorks has occupied...

Continue reading

On the acquiring a wind farm project

On the acquiring a wind farm project in Poland AB “Ignitis grupė” (hereinafter – the Group) informs that on 21 December 2021 its Management Board approved the conclusion of the shares purchase agreement (hereinafter – the Agreement) whereby its subsidiary UAB “Ignitis renewables” (hereinafter – Ignitis Renewables) acquired 100% of the shares of the Polish company developing a wind farm in Poland. The total capacity of the wind farm under development in Poland is 50 MW. The project is currently in an advanced stage of development with construction permits obtained and contract for difference (CfD) tariff of 237.5 PLN/MWh (around 51 EUR/MWh) awarded in the Polish renewable energy auction, its estimated commercial operations date is around 2023. The conclusion of the Agreement is foreseen in the upcoming few days and will not be communicated...

Continue reading

On the acquiring a wind farm project in Poland

AB “Ignitis grupė” (hereinafter – the Group) informs that on 21 December 2021 its Management Board approved the conclusion of the shares purchase agreement (hereinafter – the Agreement) whereby its subsidiary UAB “Ignitis renewables” (hereinafter – Ignitis Renewables) acquired 100% of the shares of the Polish company developing a wind farm in Poland. The total capacity of the wind farm under development in Poland is 50 MW. The project is currently in an advanced stage of development with construction permits obtained and contract for difference (CfD) tariff of 237.5 PLN/MWh (around 51 EUR/MWh) awarded in the Polish renewable energy auction, its estimated commercial operations date is around 2023. The conclusion of the Agreement is foreseen in the upcoming few days and will not be communicated separately. Total preliminary investments,...

Continue reading

CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies

SAN DIEGO, Dec. 21, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19 diagnostics, oncological research, and dry eye disease, announced today that the Centers for Disease Control and Prevention (CDC) highlighted a study that the Company sponsored on neutralizing antibodies in its recent COVID-19 Science Update: Edition 116. Using AXIM’s rapid neutralizing antibody test, Dr. Douglas Lake and Alexa Roeder, co-lead authors of the study, reported that 25% of two-dose RNA vaccine recipients did not generate high levels of neutralizing antibodies (

Continue reading

Tenable recognized for award-winning workplace in 2021

Most recent accolades include four top honors for company culture, CEO rating and more COLUMBIA, Md., Dec. 21, 2021 (GLOBE NEWSWIRE) — Tenable®, the Cyber Exposure company, today celebrated its recognition as a premiere workplace in 2021. Most recently, the company was honored by Comparably for the following categories throughout December:Best Company Culture: Tenable given an A+ overall culture score. Best CEO: Amit Yoran was ranked in the top 5% of CEOs for similarly sized companies. Best Company for Women: Tenable’s Gender Score, which tracks how positively women rate their experience at a company, was ranked in the top 5% for similarly sized companies. Best Company for Diversity: Tenable’s Diversity Score, which tracks how positively diverse employees rate their experience at a company, was ranked in the top 10% for similarly...

Continue reading

BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales

Leading healthcare management firm to enhance the Company’s market access strategy as it expands the installation base of its signal processing technology for arrhythmia care Westport, CT, Dec. 21, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it appointed Access Strategy Partners, Inc. to advise on the next phase of the commercial roll-out. Led by medical device sales experts, Boston-based Access Strategy Partners brings to BioSig deep expertise in commercialization, contract management, execution, and value proposition optimization. The company’s Co-Founder...

Continue reading

Syneos Health Releases 2022 Health Trends

New Era of Biopharma Product Development to be Fueled by Value Creation, Human Centricity and Industry Change MORRISVILLE, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released 2022 Health Trends: Insights for Industry Change Agents. From patient-powered design to accelerated integration across the product lifecycle, this year’s Trends report empowers organizations to be catalysts for change by anticipating what’s to come. Trends for 2022 focus on new models for creating stakeholder value, the importance of prioritizing human relationships at every healthcare encounter and strengthening technology-enabled insights to speed the delivery of life-changing therapies to patients. “If there’s one through line in this year’s report, it’s...

Continue reading

Record year for Verizon Frontline public safety technology deployments

BASKING RIDGE, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) — As first responders continue emergency response efforts in communities across multiple states following last week’s devastating tornadoes, the Verizon Response Team remains deployed in support of local public safety agencies to ensure they have the mission-critical communications capabilities they need. This support, provided at no cost to the responding agencies and lasting as long as there is a need, is the latest in a series of 2021 deployments during which the Verizon Response Team delivered Verizon Frontline technology to first responders as they dealt with crises ranging from extreme weather events and wildfires to the ongoing response to the COVID-19 pandemic. A year of unique challenges, 2021 saw the Verizon Response Team deploy more than 1,000 times to just over 700...

Continue reading

Lisa Walker Joins Gevo as Assistant General Counsel

ENGLEWOOD, Colo., Dec. 21, 2021 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ:GEVO), announced today that Lisa Walker has joined Gevo as Assistant General Counsel. Ms. Walker brings more than 25 years of experience in commercial contracts and negotiation, litigation management, marketing and trading, real estate transactions, liability and risk assessment, and asset acquisition and divestiture. Most recently, she served as Assistant General Counsel – Commercial Transactions Attorney at Kinder Morgan, Inc. “I’d like to issue an enthusiastic welcome to Lisa,” said Geoff Williams, General Counsel. “She is a trading and marketing veteran in the energy commodity space, including the natural gas, crude and crude oil products, natural gas liquids, wholesale propane, power, and renewables sectors. She will bolster the legal team by reviewing,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.